Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
08/02/2006 | EP1684810A1 Polybiotin compounds for magnetic resonance imagining and drug delivery |
08/02/2006 | EP1684779A1 Method for controlling angiogenesis in animals |
08/02/2006 | EP1578416B1 Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles |
08/02/2006 | EP1478380B1 Use of tyrosine kinase inhibitors for treating cns disorders |
08/02/2006 | EP1450843B1 Use of thymulin-like peptides for making pain-relieving medicines |
08/02/2006 | EP1430050B1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
08/02/2006 | EP1412362B1 THIENO¬2,3-d|PYRIMIDINEDIONES AS INHIBITORS OF T-CELLS PROLIFERATION |
08/02/2006 | EP1395242B1 Liquid pharmaceutical composition |
08/02/2006 | EP1330459B1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
08/02/2006 | EP1274692B1 Quinazoline compounds |
08/02/2006 | EP1267828B1 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
08/02/2006 | EP1246616B1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
08/02/2006 | EP1210341B1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
08/02/2006 | EP1165137B1 Sphingomyelin containing preparation for the enhancement of tumor therapy |
08/02/2006 | EP1133476B1 Iminoguanidine derivatives, preparation method, use as medicines |
08/02/2006 | EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
08/02/2006 | EP1001785B1 Use of colchinol derivatives as vascular damaging agents |
08/02/2006 | EP0866713B1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
08/02/2006 | CN1812805A Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
08/02/2006 | CN1812802A Formulations for the treatment of arhritis conditions |
08/02/2006 | CN1812787A 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors |
08/02/2006 | CN1810958A Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
08/02/2006 | CN1810822A 2-aminocarbonyl-9h-purine derivatives |
08/02/2006 | CN1810794A Prepn process and medicine composition of dewatered andrographolide |
08/02/2006 | CN1810286A Externally applied plaster |
08/02/2006 | CN1810284A Yunnan Rhizoma Paridis extract and its prepn, medicinal use and medicine composition |
08/02/2006 | CN1810280A Medicine composition for treating rheumatism, rheumatoidal diseases, etc. and its prepn process |
08/02/2006 | CN1810276A Externally applied medicinal wine for treating rheumatism |
08/02/2006 | CN1810267A Puerariae Decoction mixture preparing process |
08/02/2006 | CN1810238A Oral arginine prepn for preventing and treating cachexia syndrome |
08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
08/02/2006 | CN1267451C Somatostatin analogues |
08/02/2006 | CN1267423C Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists |
08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
08/02/2006 | CN1267394C Vitamin D analogues |
08/02/2006 | CN1267117C Chinese medicine composition for curing traumatic injury and pains in chest and hypochondrium and its preparing method |
08/02/2006 | CN1267108C Medication for treating painful symptoms of the illness |
08/02/2006 | CN1267107C Extraction method of scorpion active protein liquid |
08/02/2006 | CN1267098C Usage of treating allergic rhinitis and other disorders using descarboethoxyloratadine |
08/02/2006 | CN1267087C Pharmaceutical tablet |
08/02/2006 | CN1267024C Tryptophan source from plants and uses therefor |
08/01/2006 | US7084172 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics |
08/01/2006 | US7084161 Method for treating inflammatory diseases or conditions |
08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
08/01/2006 | US7084148 Analgesics; antipyretics; antiinflammatory agents |
08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
08/01/2006 | US7084122 Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents |
08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
08/01/2006 | US7084113 comprises a successfully elucidated crystal structure of a glycoprotein-binding protein originating from snake venom |
08/01/2006 | US7084109 FVIIa antagonists |
08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
08/01/2006 | US7083785 Tumor necrosis factor family and its blocking agent |
08/01/2006 | CA2379903C Novel benzotriazoles anti-inflammatory compounds |
08/01/2006 | CA2277990C 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
08/01/2006 | CA2255668C Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use |
08/01/2006 | CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors |
07/28/2006 | CA2497820A1 A cream formulation of steroid and diphenhydramine |
07/27/2006 | WO2006079077A2 Use of diltiazem or analogs thereof as modulators of ghrelin receptor |
07/27/2006 | WO2006078907A1 2-substituted benzimidazole derivatives as vanilloid receptor ligands and their use in treatments |
07/27/2006 | WO2006078834A1 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
07/27/2006 | WO2006077497A1 Crystalline forms cis-5-fluoro-n-[4-(2-hydroxy-4-methylbenzamido) cyclohexyl]-2-(tetrahydrothiopyran-a-yloxy) nicotinamide |
07/27/2006 | WO2006077412A1 Thienopyrroles useful in the treatment of inflammation |
07/27/2006 | WO2006077401A1 Pyrrolopyridines useful in the treatment of inflammation |
07/27/2006 | WO2006077367A1 Indoles useful in the treatment of inflamation |
07/27/2006 | WO2006077366A1 Indoles useful in the treatment of inflammation |
07/27/2006 | WO2006077365A1 Indoles useful in the treatment of inflammation |
07/27/2006 | WO2006077364A1 Indoles useful in the treatment of inflammation |
07/27/2006 | WO2006077168A1 Pyrazolopyridines, their preparation and their medical use |
07/27/2006 | WO2006076844A1 Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof |
07/27/2006 | WO2006044582A3 Use of baff to treat sepsis |
07/27/2006 | WO2005114206A3 Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a) |
07/27/2006 | WO2005097090A3 AGENTS THAT DISRUPT PSD95 - nNOS INTERACTION, COMPOSITIONS CONTAINING THE SAME, AND THERAPEUTIC USES THEREOF |
07/27/2006 | US20060168672 B7-like molecules and uses thereof |
07/27/2006 | US20060167267 Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and the conversion of a ester moiety into an amino moiety; S)-2-methylcysteine; desferrithiocin |
07/27/2006 | US20060167261 e.g. N-(4-Chloro-3-trifluoro methyl phenyl)-2-[3-(4-pyridinyloxy)phenyl amino]-acetamide; serine/threonine kinase inhibitor; anticarcinogenic, antiproliferative, antidiabetic agent; autoimmune diseases; atherosclerosis, arthritis, Crohn's disease, retinopaty |
07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
07/27/2006 | US20060167086 Medicinal composition |
07/27/2006 | US20060167083 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
07/27/2006 | US20060167082 4-Nitrooxybutyl 4-(2,6-Dichlorophenylamino)-thiophen-3-ylacetate; cytoprotective nitric oxide releasing nonsteroidal antiinflammatory agents; cyclooxygenase inhibitors; reduced side effects |
07/27/2006 | US20060167062 Enema preparation |
07/27/2006 | US20060167052 Piperidine derivative, process for producing the same, and use |
07/27/2006 | US20060167049 Terphenly derivatives, preparation thereof, compositions containing same |
07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
07/27/2006 | US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
07/27/2006 | US20060167038 2E)-3-{3-cyano-4,6-dimethyl-1-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1H-pyrrolo[2,3-b]pyridin-2-yl}-N-(3,4-dimethoxyphenyl)prop-2-enamide; preventive, therapeutic agent and analgesic for overactive bladder |
07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
07/27/2006 | US20060167011 Inhibitors of phosphorylation of platelet derived growth factor receptor |
07/27/2006 | US20060167007 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
07/27/2006 | US20060167003 Probucol derivatives |
07/27/2006 | US20060167002 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
07/27/2006 | US20060166996 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
07/27/2006 | US20060166990 Novel aminobenzophenone compounds |
07/27/2006 | US20060166989 2-naphthamide derivatives |
07/27/2006 | US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
07/27/2006 | US20060166961 Cell adhesion inhibitors |
07/27/2006 | US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases |